Olga Kubassova, PhD[email protected]Nuclear MedicineHow medical imaging can accelerate drug developmentIt can take 15 years to get a drug candidate from the lab to approval. Could medical imaging speed up that process? Olga Kubassova, PhD, of Image Analysis Group explains how imaging modalities such as MRI, CT, and PET are helping to track biomarkers in clinical studies, potentially bringing lifesaving therapies to patients more quickly.January 21, 2019Page 1 of 1Top StoriesInterventionalGAE reduces pain biomarkers in knee osteoarthritisGenicular artery embolization (GAE) significantly reduces key biomarkers that drive pain in patients with knee osteoarthritis.Residents/FellowsRace, ethnicity influence educational debt among radiology-bound MDsMRIMRI, CT findings correlate for assessing epicardial fat volumePractice ManagementImaging experts hope NSA enforcement bill delivers on accountabilityCTPET/CT identifies bone demineralization in breast cancer patients
